Ang Wei

565 total citations
38 papers, 275 citations indexed

About

Ang Wei is a scholar working on Hematology, Infectious Diseases and Immunology. According to data from OpenAlex, Ang Wei has authored 38 papers receiving a total of 275 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hematology, 18 papers in Infectious Diseases and 16 papers in Immunology. Recurrent topics in Ang Wei's work include Autoimmune and Inflammatory Disorders Research (21 papers), Parvovirus B19 Infection Studies (18 papers) and Immune Cell Function and Interaction (13 papers). Ang Wei is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (21 papers), Parvovirus B19 Infection Studies (18 papers) and Immune Cell Function and Interaction (13 papers). Ang Wei collaborates with scholars based in China, Russia and United States. Ang Wei's co-authors include Zhigang Li, Honghao Ma, Hongyun Lian, Dong Wang, Yunze Zhao, Qing Zhang, Rui Zhang, Tianyou Wang, Lei Cui and Weijing Li and has published in prestigious journals such as Blood, The Journal of Infectious Diseases and The Journal of Pediatrics.

In The Last Decade

Ang Wei

32 papers receiving 270 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ang Wei China 10 178 154 121 61 43 38 275
Hongyun Lian China 10 177 1.0× 150 1.0× 142 1.2× 63 1.0× 97 2.3× 50 330
Maria Luisa Coniglio Italy 9 168 0.9× 168 1.1× 89 0.7× 15 0.2× 20 0.5× 19 279
Ramya Uppuluri India 10 119 0.7× 84 0.5× 52 0.4× 62 1.0× 16 0.4× 61 267
Hidekazu Masuoka Japan 7 219 1.2× 104 0.7× 85 0.7× 34 0.6× 14 0.3× 23 267
Zebin Luo China 9 128 0.7× 75 0.5× 62 0.5× 40 0.7× 18 0.4× 30 254
Benedetta Ciambotti Italy 7 183 1.0× 157 1.0× 102 0.8× 9 0.1× 18 0.4× 7 248
Peifang Xiao China 6 121 0.7× 50 0.3× 47 0.4× 32 0.5× 16 0.4× 41 175
Najla El Jurdi United States 9 119 0.7× 35 0.2× 28 0.2× 78 1.3× 32 0.7× 50 246
Friederike S. Schuster Germany 8 179 1.0× 135 0.9× 110 0.9× 17 0.3× 6 0.1× 10 256

Countries citing papers authored by Ang Wei

Since Specialization
Citations

This map shows the geographic impact of Ang Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ang Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ang Wei more than expected).

Fields of papers citing papers by Ang Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ang Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ang Wei. The network helps show where Ang Wei may publish in the future.

Co-authorship network of co-authors of Ang Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Ang Wei. A scholar is included among the top collaborators of Ang Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ang Wei. Ang Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zhao, Yunze, Ang Wei, Honghao Ma, et al.. (2023). Serum cytokine pattern in children with hemophagocytic lymphohistiocytosis. Annals of Hematology. 102(4). 729–739. 12 indexed citations
3.
Ge, Jian, Qing Zhang, Honghao Ma, et al.. (2023). Ruxolitinib-based regimen in children with primary hemophagocytic lymphohistiocytosis. Haematologica. 109(2). 458–465. 15 indexed citations
4.
Cui, Lei, Hongyun Lian, Li Zhang, et al.. (2023). Clinical outcomes and prognostic risk factors of Langerhans cell histiocytosis in children: Results from the BCH‐LCH 2014 protocol study. American Journal of Hematology. 98(4). 598–607. 16 indexed citations
5.
Wei, Ang, Guanyun Wang, Lijuan Feng, et al.. (2023). The baseline metabolism parameters of 18F‑FDG PET/CT as promising prognostic biomarkers in pediatric Langerhans cell histiocytosis. Quantitative Imaging in Medicine and Surgery. 13(9). 5934–5944.
6.
Wei, Ang, et al.. (2023). Allogeneic hematopoietic stem cell transplantation for pediatric acute lymphoblastic leukemia. Annals of Hematology. 103(1). 297–305. 1 indexed citations
7.
Zhao, Yunze, Ang Wei, Honghao Ma, et al.. (2023). Subcutaneous panniculitis-like T-cell lymphoma associated with hemophagocytic lymphohistiocytosis: a systematic review of 63 patients reported in the literature. Clinical and Experimental Medicine. 23(8). 4575–4583. 3 indexed citations
8.
Wang, Dong, Xihua Chen, Ang Wei, et al.. (2022). Clinical features and treatment outcomes of pediatric Langerhans cell histiocytosis with macrophage activation syndrome-hemophagocytic lymphohistiocytosis. Orphanet Journal of Rare Diseases. 17(1). 151–151. 8 indexed citations
9.
Yang, Jun, Ang Wei, Guanghua Zhu, et al.. (2021). Haploidentical hematopoietic stem cell transplantation for pediatric patients with chronic active Epstein–Barr virus infection: a retrospective analysis of a single center. World Journal of Pediatrics. 17(6). 626–636. 5 indexed citations
10.
Lian, Hongyun, Ang Wei, Lejian He, et al.. (2021). Clinical Analysis of Pediatric Systemic Juvenile Xanthogranulomas: A Retrospective Single-Center Study. Frontiers in Pediatrics. 9. 672547–672547. 4 indexed citations
11.
Ma, Honghao, Ping Zhang, Ang Wei, et al.. (2021). Outcome of L-DEP regimen for treatment of pediatric chronic active Epstein–Barr virus infection. Orphanet Journal of Rare Diseases. 16(1). 269–269. 9 indexed citations
12.
Zhu, Guanghua, Ang Wei, Bin Wang, et al.. (2021). Haploidentical haematopoietic stem cell transplantation for malignant infantile osteopetrosis and intermediate osteopetrosis: a retrospective analysis of a single centre. Orphanet Journal of Rare Diseases. 16(1). 314–314. 8 indexed citations
13.
Wei, Ang, Honghao Ma, Liping Zhang, et al.. (2021). Clinical analysis of chronic active EBV infection with coronary artery dilatation and a matched case–control study. Orphanet Journal of Rare Diseases. 16(1). 50–50. 6 indexed citations
14.
Chen, Sitong, Ang Wei, Honghao Ma, et al.. (2021). Clinical Features and Prognostic Factors of Children with Chronic Active Epstein-Barr Virus Infection: A Retrospective Analysis of a Single Center. The Journal of Pediatrics. 238. 268–274.e2. 7 indexed citations
15.
Lian, Hongyun, Lei Cui, Ying Yang, et al.. (2021). Second-line regimen for CNS-involved pediatric Langerhans cell histiocytosis. Pituitary. 25(1). 108–115.
16.
Li, Na, Lei Cui, Honghao Ma, et al.. (2020). Osteopontin is highly secreted in the cerebrospinal fluid of patient with posterior pituitary involvement in Langerhans cell histiocytosis. International Journal of Laboratory Hematology. 42(6). 788–795. 5 indexed citations
17.
Zhang, Tianlei, et al.. (2020). Spontaneous regression of optic pathway glioma in children: report of three cases and review of literature. 32(3). 182–185. 1 indexed citations
18.
Wei, Ang, Honghao Ma, Zhigang Li, et al.. (2020). Short-term effectiveness of ruxolitinib in the treatment of recurrent or refractory hemophagocytic lymphohistiocytosis in children. International Journal of Hematology. 112(4). 568–576. 19 indexed citations
19.
Zhang, Qing, Ang Wei, Honghao Ma, et al.. (2020). A pilot study of ruxolitinib as a front-line therapy for 12 children with secondary hemophagocytic lymphohistiocytosis. Haematologica. 106(7). 1892–1901. 43 indexed citations
20.
Wei, Ang & Zhigang Li. (2019). Research progress of pathogenesis and treatment of hemophagocytic lymphohistiocytosis. Zhonghua shiyong erke linchuang zazhi. 34(3). 227–230. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026